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Different Gene Expression Patterns in Human
Papillary and Reticular Fibroblasts
David G. Janson1, Gae¨lle Saintigny2, Adam van Adrichem1, Christian Mahe´2 and Abdoelwaheb El Ghalbzouri1
The dermis contains two distinct layers: the papillary and the reticular layers. In vitro cultures of the fibroblasts
from these layers show that they are different. However, no molecular markers to differentiate between the two
subtypes of fibroblasts are known. We performed gene expression analysis on cultured fibroblasts isolated
from the papillary and reticular dermis. In all, 116 genes were found to be expressed differentially. Of these,
13 were validated by quantitative reverse transcriptase–PCR analysis and two markers could be validated at
the protein level in monolayer cultures. Three markers showed differential expression in in vivo skin sections.
The identified, characteristic markers of the two fibroblast subpopulations provide useful tools to perform
functional studies on reticular and papillary fibroblasts.
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INTRODUCTION
Originally believed to be a relatively uninteresting cell
population, fibroblasts have become a main focus of research
interest. On one hand, this is based on the easy isolation and
culture techniques required to obtain fibroblasts from human
skin. On the other hand, because fibroblasts have shown to be
a very dynamic cell population involved in many physiolo-
gical processes, definitely not restricted to matrix homeostasis.
These include communication with vasculature, nervous
system and epithelial tissues, the immune response, and
wound healing (Sorrell and Caplan, 2009). Furthermore,
fibroblasts are known to be involved in several disease-related
processes, for example, cancer invasion (Kalluri and Zeisberg,
2006). Another important role of fibroblasts is their implica-
tion in the aging process. Because skin fibroblasts are easily
accessible, a lot of aging research is performed on monolayer
fibroblast cultures (e.g. Maier and Westendorp, 2009).
Fibroblasts from different locations and tissues are distinct
(Chang et al., 2002; Rinn et al., 2006, 2008). This is also true
for their location within the skin where they populate the two
dermal layers, the superficial papillary dermis (300–400 mm)
and the underlying reticular dermis. The papillary dermis is
characterized by a relatively thin extracellular matrix and a
high cell density, whereas the reticular dermis has a very
dense network of matrix fibers and a low cell density (Ross
and Pawlina, 2011). The constituents of the matrix are also
distinct in the two layers, in particular decorin is found
primarily in the papillary dermis (Schonherr et al., 1993).
Other matrix constituents that differ between the papillary
and reticular dermis include, but are not limited to: versican,
collagen IV, collagen XII, and collagen XVI (Sorrell and
Caplan, 2004).
When fibroblasts of the respective layers are cultured, they
preserve distinct morphological characteristics. Reticular
fibroblasts have a squarer and stretched appearance, while
papillary fibroblasts generally have a lean, spindle-shaped
morphology. Furthermore, differences were found in prolif-
eration (Harper and Grove, 1979; Azzarone and Macieira-
Coelho, 1982), matrix production in culture (Tajima and
Pinnell, 1981; Schonherr et al., 1993; Izumi et al., 1995),
response to growth factors (Feldman et al., 1993; Tajima and
Izumi, 1996), and production of growth factors (Sorrell et al.,
2004; Mine et al., 2008).
The potential relevance of reticular and papillary fibro-
blasts with respect to skin aging was recently explored by
Mine et al. (2008). Two of the most notable markers of aged
skin are a decrease of the dermal volume (atrophy) and the
loss of rete ridges, the wave-like appearance of the
dermal–epidermal junction (Gilchrest and Krutmann, 2006;
Makrantonaki and Zouboulis, 2007). It was hypothesized that
one of the causes of this aging phenotype is the loss of the
papillary dermal compartment. More specifically, it was
speculated that papillary fibroblasts (or the papillary pheno-
type) are lost and replaced by reticular fibroblasts. Since
reticular fibroblasts are different from their papillary counter-
parts, this could cause changes in the skin microenvironment
that contribute to aging. Potentially affected attributes include
skin elasticity, matrix production and degradation, epidermal
interaction, and basement membrane homeostasis. To study
these processes in more detail, and to identify the specific
role of the fibroblast subpopulations, distinct molecular
markers are needed.
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The aim of this study was to identify differentially
expressed genes in both subpopulations, and subsequently
validate these potential markers at the protein level.
RESULTS
Distinct morphology of papillary and reticular fibroblasts
Cultured reticular and papillary fibroblasts revealed morpho-
logical characteristics as described in the literature (e.g. Mine
et al., 2008; Sorrell and Caplan, 2009). Papillary fibroblasts
exhibit a spindle-shaped morphology, whereas reticular
fibroblasts are characterized by a more flattened appearance
and have a higher percentage of cells with expression of
the myofibroblast marker a-smooth muscle actin (a-SMA).
Representative pictures are shown in Figure 1b. In addition,
papillary fibroblasts showed increased proliferative capacity
(Figure 1c).
Differentially expressed genes in reticular and papillary
fibroblasts
Gene expression analysis revealed 116 probes differently
expressed in reticular and papillary fibroblasts (adjusted
P-value o0.05). Figure 2 shows a heatmap of the 50 most
significant probes. All significant probes are listed in
Supplementary Table S1 online.
In reticular fibroblasts, genes belonging to the smooth
muscle contraction pathway were particularly overex-
pressed, in line with the fact that reticular populations
contain more a-SMA-positive fibroblasts. GO term analysis
of our data showed that reticular fibroblasts contain
predominantly genes involved in cytoskeletal organization,
cell motility, and neuronal development. Papillary fibro-
blasts showed a high expression level of genes belonging to
the complement activation pathway, indicating an implica-
tion in the skin immune response system. This was con-
firmed by investigating the GO terms, which showed
enrichment for immune response, host defense, and com-
plement activation.
Three reference genes were selected by quantitative
reverse transcriptase–PCR (qPCR) following GeNorm analy-
sis: SND1, TBP, and EI24. In total, 16 significantly different
genes from the gene expression data were chosen to be
validated by qPCR. Of these, 13 were also significantly
different in the qPCR analysis (Figure 3).
Figure 1. Culture of papillary and reticular fibroblasts. (a) Schematic
representation of the isolation of reticular and papillary fibroblasts. For
papillary fibroblasts, the epidermis and part of the upper dermis are
dermatomed (300mm). Reticular fibroblasts are taken from the deep dermis by
dermatoming at 700 mm and using the dermis beneath the dermatomed tissue.
(b) Monolayer characteristics of both fibroblast populations. Differences were
found in cell morphology, as determined by bright-field microscopy and
vimentin staining (intermediate filament). Furthermore, reticular fibroblasts
have a higher expression of a-smooth muscle actin (a-SMA). Scale
bar¼ 50 mm. (c) Growth curve of reticular and papillary fibroblasts. Points
show the average number of cells from three different donors. Reticular
fibroblasts grow significantly slower than papillary fibroblasts, as determined
by a paired t-test at day 10 (Po0.05, t-test, three different donors).
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Validation of biomarkers on protein level
Of the genes that were confirmed by qPCR, five were selected
for further validation at the protein level. These were CCRL1
(C–C chemokine receptor type 11), MGP (matrix Gla protein),
NTN1 (netrin-1), PDPN (podoplanin), and TGM2 (transglu-
taminase 2). The selection was based on a high LogFC and
expression at the cell surface (except TGM2, which is
expressed intracellularly). Only two of these, TGM2 and
PDPN, could be validated by western blot analyses on cell
lysates of the same donors used in the array experiment
(Figure 4a). The antibodies for the other targets did not work
with this approach. Furthermore, CCRL1 did not show any
difference in expression (data not shown). Next, we wanted
to confirm the expression of TGM2 and PDPN in monolayer
cultures of reticular and papillary fibroblasts. PDPN showed
strong expression in papillary fibroblasts and weak staining in
reticular fibroblasts, whereas TGM2 was expressed in most,
but not all, reticular fibroblasts and only occasionally in
papillary fibroblasts (Figure 4b). For the other targets, we tried
immunohistochemical analyses on in vivo paraffin sections of
female donors. As expected from our gene expression data,
MGP was strongly expressed and abundantly present in the
reticular dermal matrix (Figure 5). The MGP-negative band
underneath the epidermis decreased in size in aged donors,
suggesting a loss of papillary dermis during aging. Although
the antibodies tested for NTN1 and PDPN showed back-
ground staining in the epidermis, both proteins were highly
expressed in singular cells in the upper dermis (Figure 6).
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Figure 2. Heatmap of 50 most significant probes. On the x axis, the arrays are listed, pap or ret designating the cell type, and the numbers indicate the donor.
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Figure 3. Quantitative PCR validation. Analyses showing that 13 out of 16
target genes were also significantly expressed by PCR. The tested genes are
shown on the x axis and the normalized fold expression on the y axis. The
normalized fold expression is based on the reference genes SND1, TBP, and
EI24. Error bars show SEM. *Po0.05, #Po0.01 (paired t-test).
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However, there were also cells in the deeper dermis that were
positive and negative cells in the upper dermis (Figure 6b). As
such, they are not very suitable to differentiate between the
papillary and reticular dermis, as there is no clear boundary
between positively stained fibroblasts and negatively stained
fibroblasts. The target CCRL1 could not be validated on pro-
tein level in fibroblasts cultures and in vivo biopsies, while TGM2
showed a highly variable expression in in vivo biopsies.
DISCUSSION
Two antibodies that selectively detect the papillary dermis
have been characterized before (Sorrell et al., 1999, 2003).
However, no specific biomarkers for either the papillary or
reticular fibroblasts themselves have been described. By
using microarray analysis, we have found 116 genes that
are differentially expressed in reticular and papillary
fibroblasts. Two genes (PDPN and TGM2) were validated
at the protein level in monolayer fibroblast cultures. The
most promising marker for reticular fibroblasts was MGP,
almost exclusively expressed in the reticular dermis
in vivo. Even though PDPN and NTN1 showed generally
a higher expression in in vivo papillary fibroblasts, their
use as in vivo markers seemed limited because of the
highly variable staining.
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Figure 4. In vitro validation of markers on protein level. (a) Western blot analyses showing that transglutaminase 2 (TGM2) and podoplanin (PDPN) are also
differently expressed between reticular and papillary fibroblasts. Donor designates the donor number and the type of fibroblast subpopulation (p¼papillary;
r¼ reticular). (b) Immunohistochemical analyses on monolayer cultures of papillary and reticular fibroblasts isolated from three different donors. TGM2 was
strongly expressed in reticular fibroblasts and PDPN was more expressed in papillary fibroblasts. Scale bar¼ 50 mm.
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Figure 5. Immunohistochemical analyses of the reticular marker matrix Gla protein (MGP) on in vivo sections from mammary and abdominal
skin of nine donors. Although the antibody against MGP shows some background staining in the epidermis, a high expression in the reticular dermis and
weak or no expression in the papillary dermal layer could be observed. This indicates that this marker can clearly separate between both dermal layers.
Scale bar¼ 50 mm.
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Figure 6. Protein expression of papillary markers netrin-1 (NTN1) and podoplanin (PDPN) in vivo. (a) Immunohistochemical analyses of the NTN1 and PDPN
in in vivo sections of two donors (mammary skin). (b) High magnification pictures of the papillary and reticular dermis. Although both antibodies show staining
in the epidermis, both proteins were found mainly expressed in the fibroblasts underneath the epidermis. However, some fibroblasts stained positive for these
antibodies in the reticular dermis, while some fibroblasts stained negative for these antibodies in the papillary dermis. Scale bar¼ (a) 50 mm and (b) 25 mm.
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One of our objectives was the identification of markers
that could be used to separate the two fibroblast populations.
Most of the markers we found were not exclusively expressed
in one of the populations, neither in vivo nor in cultures. This
begs the question whether the two populations are homo-
genous. Earlier findings showed that within the fibroblast
populations there is heterogeneity (Sorrell et al., 2007). Even
though the markers we identified are useful to determine the
phenotype of a fibroblast population, they are less specific if
only a few cells are available.
The exact role of the genes found differently expressed
between reticular and papillary fibroblasts remains unknown.
Some genes could be grouped based on their similar
functions, but no individual signaling pathways were found
that were clearly distinct. This could be caused by the relative
small sample size and the low number of significant genes to
work with in the functional analysis. However, based on the
GO terms, it appears that reticular fibroblasts show increased
expression of genes involved in cell motility and contraction.
In our experience, reticular fibroblasts show more contraction
in human skin equivalents than papillary fibroblasts. Several
validated, reticular markers are associated with myofibro-
blasts: calponin 1, PPP1R14A, and transglutaminase 2
(Tomasek et al., 2006; Huang et al., 2009; Kulkarni et al.,
2011). In addition, TGM2 is linked to transforming growth
factor-ß1 (TGF-ß1) activation (Cao et al., 2012). In turn, TGF-
ß1 is associated with matrix production and myofibroblast
differentiation. This is similar to two properties of the reticular
population: high matrix density and an increased number of
a-SMA-positive cells. Accordingly, TGF-ß1 may be an
important factor involved in the differentiation between
papillary and reticular fibroblasts.
The increase of a-SMA-positive fibroblasts in the reticular
population could be explained in several, non-exclusive
ways. First, reticular fibroblasts contain more a-SMA-positive
cells to begin with. It has been shown that deep dermal
fibroblasts contain more a-SMA (myofibroblasts) and have
increased TGF-ß1 production (Wang et al., 2008). Second,
the reticular fibroblasts represent a more differentiated state
than papillary fibroblasts and consequently express more
fibroblast differentiation markers, such as a-SMA (Bayreuther
et al., 1988; Izumi et al., 1995; Mine et al., 2008). And
finally, it is possible that reticular fibroblasts have a greater
propensity to differentiate into a-SMA-positive cells in vitro.
This, in turn, could be caused by greater TGF-ß1 production
and greater responsiveness to TGF-ß1 of reticular fibroblasts.
MGP was the only gene that showed a strong differential
expression in vivo. Its function in the skin is unknown,
although it is believed to play a role in (inhibition of)
calcification of matrix molecules (Davies et al., 2006;
Gheduzzi et al., 2007). Interestingly, MGP shows intense
staining in the terminally differentiated layers of the
epidermis (Figure 5). It is possible that MGP is involved in
the density of the tissue (Cancela et al., 1997); MGP
expression is increased in dense tissues. This corresponds to
the fact that the reticular dermis is denser than the papillary
dermis. In addition, it can be an explanation for the lack of
differential protein levels of MGP between monolayer
cultures of papillary and reticular cultures, because these
experiments were not performed on high-density cultures.
The papillary markers were enriched for genes involved in
the immune response. Since papillary markers are close to
the epidermis, and therefore the outside world, it is likely that
they play a role in host defense. However, no clear pathway
or process in host defense could be singled out among the genes
that showed increased expression in papillary fibroblasts.
Countless questions remain regarding the role of these
fibroblast populations in skin physiology, especially their role
in relation to skin aging. One of the most prominent markers
of skin aging is the loss of rete ridges and the flattening dermis.
Mine et al. (2008) showed that fibroblasts in the papillary
dermis are more affected by aging and hypothesized that the
papillary dermis and fibroblasts disappear during aging. This
leads to a (relative) increase in the reticular volume and could
explain, based on the in vitro differences between reticular and
papillary fibroblasts, certain aspects of skin aging. One of the
markers we have found, MGP, confirms the increase of
papillary atrophy with age and a reduced cell density. These
findings were most striking in donors of post-menopausal age.
An interesting question is what causes the loss of the
papillary dermis in aged skin. UV seems an obvious
candidate, but the phenotype is also found in unexposed
skin. Dermabrasion of (usually photo-) aged skin rejuvenates
it, including a restoration of the papillary dermis (Freedman
et al., 2001). This suggests that aged skin is still capable of
generating a papillary dermis, but that this is somehow
suppressed. Stimulating the skin to (re)generate the papillary
dermis looks like a promising way to combat skin aging.
In conclusion, we have identified several markers to distin-
guish fibroblasts from the papillary and reticular dermis. They
can be used in vitro on both RNA and protein level, and ex vivo
for immunohistochemical analysis, in particular MGP. The
identified markers may prove useful in further functional studies
of the populations and their respective role in skin aging.
MATERIALS AND METHODS
Isolation and cell culture
Five female, Caucasian donors aged 39–49 years were used for the
isolation of the fibroblasts. Of all donors, both reticular and papillary
were isolated. Consequently, all analyses were performed on a
pairwise basis. Isolation was performed as described in the literature
(Sorrell et al., 2004; Mine et al., 2008). In short, skin obtained from
plastic surgery (mamma reduction or abdominal correction) was
cleaned thoroughly and dermatomed at two different depths. First, a
300mm piece was taken, containing the epidermis and papillary
dermis. For the reticular dermis, the skin was dermatomed at
700mm, and the upper part was discarded. The remaining (deep)
dermis was used for fibroblast isolation. A schematic overview of this
procedure is given in Figure 1a. Fibroblasts were isolated by
treatment with collagenase (Invitrogen, Breda, The Netherlands)/
dispase (Roche Diagnostics, Almere, The Netherlands) (3:1) for
2 hours at 37 1C. The cells were subsequently filtered with a 70 mm
cell strainer and cultured in DMEM medium (Invitrogen) containing
5% fetal calf serum (HyClone/Greiner, Nu¨rtingen, Germany) and 1%
penicillin–streptomycin (Invitrogen). They were kept at 37 1C at 5%
CO2. Fibroblasts used for experiments were in passages 4–6.
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Patient consent was not required, because the use of surplus
material obtained in accordance with the Dutch Law on Medical
Treatment Agreement does not require patient consent.
Growth curve
For the growth curve experiment, 5,000 fibroblasts papillary or
reticular fibroblasts of three different donors were seeded into 6-well
plates. Cells were counted with a Bu¨rker-counting chamber after 3,
6, 7, and 10 days.
RNA and protein isolation
RNA and proteins were isolated from monolayer fibroblast cultures
with the RNEasy kit (Qiagen) and Mammalian Protein Extraction
Reagent (M-PER; Thermo Scientific, Etten-Leur, The Netherlands),
respectively, according to the manufacturer’s instructions. All
following experiments were performed with RNA and proteins from
a single isolation.
Microarrays
Gene expression analysis was performed by ServiceXS (Leiden, The
Netherlands). The platform was Illumina HumanHT-12 Expression
BeadChip. Data were generated with the Beadstudio software of
Illumina and analysis was performed in R (2.10.0). For the analysis, the
data were imported and normalized with the lumi package (Robust
Spline Normalization) (Du et al., 2008) and followed by the expression
analysis with the limma package (Smyth, 2004). Probes that showed
no expression in all of the arrays (detection P-value 40.05) were not
included in the analysis. For multiple testing correction, the false
discovery rate method was used (Benjamini and Hochberg, 1995).
Pathway analysis
Pathway and GO term enrichment analysis was performed with the
DAVID tool (Dennis Jr et al., 2003). Two lists were uploaded: one
with genes that were upregulated in reticular fibroblasts (adj. P-value
o0.1 and LogFC40.7) and one with genes upregulated in papillary
fibroblasts (adj. P-value o0.1 and LogFC o0.7). Both lists had
approximately 80 genes.
QRT-PCR
cDNA was generated from 1mg RNA using the iScript cDNA synthesis
kit (BioRad, Veenendaal, The Netherlands) according to manufac-
turer’s instructions. PCR reactions were based on the SYBR Green
method (BioRad). The PCRs were run on the MyIQ system (BioRad).
The PCR cycles were: 3.5minutes at 95 1C to activate the polymerase,
35 cycles of 20 seconds at 95 1C and 40 seconds at 60 1C, followed by
the generation of a melt curve. Primers were checked before on a
dilution series of normal fibroblast cDNA. Reference genes were
analyzed with the GeNorm method (Vandesompele et al., 2002).
Expression analysis was performed with the BioRad software (iQ5)
and was based on the delta delta Ct method with the reference genes
that were most stably expressed in the GeNorm analysis. The primers
are listed in Supplementary Table S2 online.
Western blot
In all, 7 mg of each protein sample was added to the loading buffer,
heated to 90 1C for 5minutes, and loaded onto a 10% SDS-PAGE
gel. Proteins were blotted on a polyvinylidene difluoride membrane
(Thermo Scientific). Blocking was performed with 5% Protifar
Plus (Nutricia, Zoetermeer, The Netherlands) in phosphate-buffered
saline-T (0.1% Tween). Primary antibodies were incubated overnight
at 4 1C. Thereafter, membranes were incubated with the appropriate
secondary antibodies, either stabilized horseradish peroxidase–
conjugated anti-mouse or anti-rabbit (Thermo Scientific; dilution
1:1,500). For detection of the bands, the Supersignal West
Femto ECL system (Thermo Scientific/Pierce) was applied to the
membrane. Bands were visualized using the G-box technology and
software.
Immunohistochemical analyses
For immunohistochemical analyses on monolayer cell cultures,
fibroblasts were grown on glass slides until nearly confluent, washed
in phosphate-buffered saline, and fixed with 4% formaldehyde.
Staining was visualized by a secondary antibody with a fluorescent
dye (Cy3). 40,6-Diamidino-2-phenylindole was used as counterstain.
Immunohistochemical analysis was performed on paraffin-em-
bedded in vivo skin sections. Slides (5 mm thick) were cut,
deparaffinized, rehydrated, and washed with phosphate-buffered
saline. Heat-mediated antigen retrieval at pH 6 was performed,
followed by a block of endogenous peroxidase and a block step
using phosphate-buffered saline/1% bovine serum albumin/2%
normal human serum. Primary antibodies were incubated overnight
at 4 1C. Staining was visualized using BrightVisionþ poly-horse-
radish peroxidase (Immunologic, Duiven, The Netherlands) accord-
ing to the manufacturer’s instructions, and 3,30 diaminobenzidine as
a chromogen. Counterstaining was performed with hematoxylin.
Antibodies
The antibodies used in this study were: a-SMA (1A4; Sigma,
Zijndrecht, The Netherlands) 1:800, CCRL1 (ab74806; Abcam,
Cambridge, UK) 1:1,000, MGP (A-11; Santa Cruz) 1:100, NTN-1 (H-
104; Santa Cruz, Santa Cruz, CA) 1:75, PDPN (18H5; Abcam)
1:1,000 (WB) and 1:100 (IHC), TGM2 (CUB7402; Abcam) 1:1,000
(WB) and 1:100 (IHC), and vimentin (V9; AbD Serotec, Du¨sseldorf,
Germany) 1:50.
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